Form D · Biotechnology

AURSOS INC

Kalamazoo, MI · CIK 0001435177

Offering snapshot reported Oct 11, 2013 · SEC filing

Reported sold: $195K
Investors reported: 2
Minimum accepted: $0
First sale: Jan 20, 2012

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$95,000 → $195,000
Reported investors1 → 2

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 11, 2013	Amendment	$195,000	$100,000vs Feb 1, 2012	2	SEC filing
Feb 1, 2012	Initial	$95,000	No comparison	1	SEC filing
Dec 29, 2010	Initial	$40,000	No comparison	1	SEC filing
Mar 2, 2010	Initial	$60,000	No comparison	1	SEC filing
Jul 14, 2009	Amendment	$560,000	No comparison	7	SEC filing
May 12, 2008	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Debt, Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-172746

Source: Form D, filed Oct 11, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Kristyn Aalto	Director
Terry Lewis	Executive
Donald R. Parfet	Director, Executive
Don Parfet	Director, Executive, Promoter
Ronald J. Shebuski	Director, Executive
Donald E. Zinn	Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:

350 E Michigan Ave Suite 500
Kalamazoo, MI, 49007